Discover your next big idea for life sciences at PACK EXPO Las Vegas
Experience a breakthrough in life sciences packaging—explore solutions from 2,300 suppliers spanning all industries, all in one place this September

FDA Authorizes First COVID/Flu OTC Test

Lucira's at-home test doesn't require a prescription, provides results in just 30 minutes, and costs $99.

Lucira Covid 19 Flu Home Test Packaging And Device Edit
Lucira

The further into the pandemic we get, the more we treat COVID-19 like the flu. So why don’t we just kill two birds with one stone? According to a recent STAT News article, that’s the plan, for testing at least. The FDA just authorized the use of the Lucira COVID-19 and flu home test kit. The kit includes a nasal swab test that provides results within 30 minutes. The test is authorized for use in people 14 and older and doesn’t require a prescription.

FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?
Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
Pharmaceutical Innovations Report